242 related articles for article (PubMed ID: 10655054)
1. Gene-target recognition among members of the myc superfamily and implications for oncogenesis.
O'Hagan RC; Schreiber-Agus N; Chen K; David G; Engelman JA; Schwab R; Alland L; Thomson C; Ronning DR; Sacchettini JC; Meltzer P; DePinho RA
Nat Genet; 2000 Feb; 24(2):113-9. PubMed ID: 10655054
[TBL] [Abstract][Full Text] [Related]
2. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
Gupta K; Anand G; Yin X; Grove L; Prochownik EV
Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
[TBL] [Abstract][Full Text] [Related]
3. Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1.
Rao G; Alland L; Guida P; Schreiber-Agus N; Chen K; Chin L; Rochelle JM; Seldin MF; Skoultchi AI; DePinho RA
Oncogene; 1996 Mar; 12(5):1165-72. PubMed ID: 8649810
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
Wu S; Peña A; Korcz A; Soprano DR; Soprano KJ
Oncogene; 1996 Feb; 12(3):621-9. PubMed ID: 8637719
[TBL] [Abstract][Full Text] [Related]
5. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
Lüscher B; Larsson LG
Oncogene; 1999 May; 18(19):2955-66. PubMed ID: 10378692
[TBL] [Abstract][Full Text] [Related]
6. Evolutionary relationships and functional conservation among vertebrate Max-associated proteins: the zebra fish homolog of Mxi1.
Schreiber-Agus N; Chin L; Chen K; Torres R; Thomson CT; Sacchettini JC; DePinho RA
Oncogene; 1994 Nov; 9(11):3167-77. PubMed ID: 7936639
[TBL] [Abstract][Full Text] [Related]
7. Repression by the Mad(Mxi1)-Sin3 complex.
Schreiber-Agus N; DePinho RA
Bioessays; 1998 Oct; 20(10):808-18. PubMed ID: 9819568
[TBL] [Abstract][Full Text] [Related]
8. Design and properties of a Myc derivative that efficiently homodimerizes.
Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S
Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1.
Pulverer B; Sommer A; McArthur GA; Eisenman RN; Lüscher B
J Cell Physiol; 2000 Jun; 183(3):399-410. PubMed ID: 10797315
[TBL] [Abstract][Full Text] [Related]
10. Sequential expression of the MAD family of transcriptional repressors during differentiation and development.
Quéva C; Hurlin PJ; Foley KP; Eisenman RN
Oncogene; 1998 Feb; 16(8):967-77. PubMed ID: 9519870
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: Differential regulation of mad family and stress-mediated induction of c-myc.
Mauleon I; Lombard MN; Muñoz-Alonso MJ; Cañelles M; Leon J
Mol Carcinog; 2004 Feb; 39(2):85-90. PubMed ID: 14750213
[TBL] [Abstract][Full Text] [Related]
12. New Myc-interacting proteins: a second Myc network emerges.
Sakamuro D; Prendergast GC
Oncogene; 1999 May; 18(19):2942-54. PubMed ID: 10378691
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc.
FitzGerald MJ; Arsura M; Bellas RE; Yang W; Wu M; Chin L; Mann KK; DePinho RA; Sonenshein GE
Oncogene; 1999 Apr; 18(15):2489-98. PubMed ID: 10229200
[TBL] [Abstract][Full Text] [Related]
14. Functions of myc:max in the control of cell proliferation and tumorigenesis.
Hurlin PJ; Dezfouli S
Int Rev Cytol; 2004; 238():183-226. PubMed ID: 15364199
[TBL] [Abstract][Full Text] [Related]
15. Low molecular weight inhibitors of Myc-Max interaction and function.
Yin X; Giap C; Lazo JS; Prochownik EV
Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
[TBL] [Abstract][Full Text] [Related]
16. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.
Yang W; Shen J; Wu M; Arsura M; FitzGerald M; Suldan Z; Kim DW; Hofmann CS; Pianetti S; Romieu-Mourez R; Freedman LP; Sonenshein GE
Oncogene; 2001 Mar; 20(14):1688-702. PubMed ID: 11313917
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence.
Giorello L; Clerico L; Pescarolo MP; Vikhanskaya F; Salmona M; Colella G; Bruno S; Mancuso T; Bagnasco L; Russo P; Parodi S
Cancer Res; 1998 Aug; 58(16):3654-9. PubMed ID: 9721875
[TBL] [Abstract][Full Text] [Related]
18. Both the helix-loop-helix and the leucine zipper motifs of c-Myc contribute to its dimerization specificity with Max.
Davis LJ; Halazonetis TD
Oncogene; 1993 Jan; 8(1):125-32. PubMed ID: 8423990
[TBL] [Abstract][Full Text] [Related]
19. Cell-cycle progression is not essential for c-Myc to block differentiation.
Ryan KM; Birnie GD
Oncogene; 1997 Jun; 14(23):2835-43. PubMed ID: 9190900
[TBL] [Abstract][Full Text] [Related]
20. Taking myc to the max.
Turner R
Nat Struct Biol; 2003 Mar; 10(3):157. PubMed ID: 12605219
[No Abstract] [Full Text] [Related]
[Next] [New Search]
